Literature DB >> 20604643

Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels.

J A Barry1, A R Kay, R Navaratnarajah, S Iqbal, J E A K Bamfo, A L David, M Hines, P J Hardiman.   

Abstract

The aetiology of polycystic ovary syndrome (PCOS) is poorly understood, but an intrauterine hyperandrogenic environment has been implicated. This study was designed to assess whether the female offspring of mothers with PCOS are exposed to raised levels of testosterone (T) in utero. In this case-control study, three groups of pregnant women were recruited from the labour ward: PCOS women with a female baby (n = 10, PCOS girls); control women with a female baby (n = 20, control girls) and control women with a male baby (n = 10, control boys). Maternal and umbilical vein (UV) blood was assayed for T levels. UV T in PCOS girls was significantly raised, compared with control girls (p < 0.012). The difference in UV T between PCOS girls and control boys was not significant (p < 0.254). This is the first demonstration of a hyperandrogenic in utero environment in PCOS pregnancies; UV T in female infants is raised to male levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20604643     DOI: 10.3109/01443615.2010.485254

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  41 in total

Review 1.  Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.

Authors:  Selma F Witchel; Sergio E Recabarren; Frank González; Evanthia Diamanti-Kandarakis; Kai I Cheang; Antoni J Duleba; Richard S Legro; Roy Homburg; Renato Pasquali; Rogerio A Lobo; Christos C Zouboulis; Fahrettin Kelestimur; Franca Fruzzetti; Walter Futterweit; Robert J Norman; David H Abbott
Journal:  Endocrine       Date:  2012-06-04       Impact factor: 3.633

2.  Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure.

Authors:  E S Barrett; K M Hoeger; S Sathyanarayana; D H Abbott; J B Redmon; R H N Nguyen; S H Swan
Journal:  J Dev Orig Health Dis       Date:  2018-01-09       Impact factor: 2.401

Review 3.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

Review 4.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

5.  Developmental programming: prenatal testosterone excess disrupts anti-Müllerian hormone expression in preantral and antral follicles.

Authors:  Almudena Veiga-Lopez; Wen Ye; Vasantha Padmanabhan
Journal:  Fertil Steril       Date:  2012-01-14       Impact factor: 7.329

Review 6.  Mechanisms of intergenerational transmission of polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Luis R Hoyos; Gregorio D Chazenbalk; Rajanigandha Naik; Vasantha Padmanabhan; David H Abbott
Journal:  Reproduction       Date:  2020-01       Impact factor: 3.906

Review 7.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

8.  Lack of Association of Vitamin D Receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) Genetic Variations with Polycystic Ovary Syndrome Risk: a Case-control Study from Iranian Azeri Turkish Women.

Authors:  Morteza Bagheri; Isa Abdi Rad; Nima Hosseini Jazani; Fariba Nanbakhsh
Journal:  Maedica (Buchar)       Date:  2012-12

Review 9.  Nonhuman primate models of polycystic ovary syndrome.

Authors:  David H Abbott; Lindsey E Nicol; Jon E Levine; Ning Xu; Mark O Goodarzi; Daniel A Dumesic
Journal:  Mol Cell Endocrinol       Date:  2013-01-29       Impact factor: 4.102

Review 10.  Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models.

Authors:  Alison V Roland; Suzanne M Moenter
Journal:  Front Neuroendocrinol       Date:  2014-04-18       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.